Purpose The management of haemorrhagic radiation proctitis is challenging because of the necessity for repeated intervention. The efficacy of argon plasma coagulation has been described before but the optimum treatment strategy remains debatable. This is a review of our experience over a decade treating patients with haemorrhagic radiation proctitis and their follow-up. Methods This is a retrospective review of consecutive patients who underwent argon plasma coagulation for haemorrhagic radiation proctitis between January 2003 and December 2013. The patients were followed up using a prospectively maintained database. Results Ninety-one patients were included with a mean follow-up of 13.1 months. Majoity (n = 85, 93.4 %) of the patients were female. Mean age at the time of treatment was 58.2 (range 23-87) years old. Majority of the patients (n = 73, 80.2 %) received radiotherapy for gynaecological malignancies followed by colorectal (n = 13, 14.3 %) and urological (n = 5, 5.5 %) malignancies. Mean interval between radiation and proctitis was 13.8 (range 3-40) months. Seventy-nine percent of patients were successfully treated after 1-2 sessions. Seventeen (18.7 %) patients experienced self-limiting early complications, and three (3.3 %) had late complications of rectal stenosis which was managed conservatively. Severity of bleeding during the initial presentation is an independent factor that predicts the number of sessions required for successful haemostasis (p = 0.002). Conclusions Argon plasma coagulation is a reasonable treatment option in patients with haemorrhagic radiation proctitis with good safety profile. Our study suggests that the number of APC sessions required to arrest bleeding correlates with the severity of bleeding on initial presentation.
Introduction
Radiation proctitis is a serious complication seen in patients who have received irradiation during the course of treatment of tumours located in the pelvis. It can be classified as either acute or chronic according to clinical presentation and time interval between symptom manifestation and last dose of radiation. Acute radiation proctitis refers to symptoms that occur within the first 3 months after radiation. Symptoms may include lower abdominal discomfort, diarrhoea, tenesmus, mucous discharge, urgency and minor rectal bleeding. Persistence of symptoms beyond 3 months after completion of radiotherapy or symptoms that begin 3 months after the initiation of radiation are defined as chronic radiation proctitis [1] . Haemorrhagic radiation proctitis (HRP) is defined as clinically significant rectal bleeding associated with characteristic mucosal changes such as telangiectasia, oedema, friability and/or ulceration [2] . Superficial vascular lesions develop due to ischemia from progressive intimal fibrosis with obliterative endarteritis [3] . The most severe forms of rectal bleeding often require repeated hospital admissions and blood transfusions. Argon plasma coagulation (APC) has been described as the most efficacious modalities in the treatment of HRP [4] . The aim of this study was to evaluate the haemostatic efficacy and the long-term outcomes of the APC in the management of HRP patients at our institution.
Methods
Ninety-one patients with haemorrhagic radiation proctitis who underwent APC in our hospital between January 2003 and December 2013 were reviewed. Full bowel preparation (oral polyethylene glycol or phospho soda) was performed if a complete colonoscopy was required. Bowel preparation by enemas was given to those requiring repeated sessions of APC treatment. Otherwise, the patients were instructed to have a strict, clear liquid diet a day before the procedure. A single-channel colonoscope (GF 165; Olympus) was used for initial assessment and subsequent therapeutic intervention of HRP. The procedure was performed under conscious sedation with patients placed in the left lateral position. ERBE Argon Plasma Coagulator ICC 200 (ERBE USA, Marietta, GA) was used with the argon gas flow rate ranging between 1.5 and 2 L/ min and an electrical power setting ranging between 50 and 60 W. APC was performed either en face or tangentially with a 2.7-mm probe using the no-touch technique. Telangiectasias were coagulated with pulses usually of 1 to 2-s duration unless they were particularly confluent.
The appearance of the affected mucosa was numerically graded 0-4 by using a previously described scale: 0, normal mucosa; 1, mild erythema; 2, diffuse erythema and punctate haemorrhage; 3, frank haemorrhage and 4, ulceration [5] . For the length of affected mucosa, it was determined by endoscopic assessment with distance measured from the anal verge. The scale used here was a distance of 10 cm or less from the anal verge, more than 10 cm but less than 20 cm, and more than 20 cm. The severity of rectal bleeding was graded 0-4, according to the criteria of Chutkan et al.: 0, no bleeding; 1, blood on paper or stool; 2, blood in toilet bowl; 3, clots and 4, bleeding requiring blood transfusion [6] . Only patients with bleeding severity of grade 2 and above were included for evaluation. Complications were defined as early when they occurred within the first month of the procedure and late when they occurred after the first month.
Results
Ninety-one patients were included in this study. The patients' characteristics and associations between various factors and number of sessions required to arrest bleeding are summarized in Table 1 . There were no major complications associated with the procedure. However, there were 17 (18.7 %) patients who had self-limiting early complications. Seven (7.7 %) had submucosal bleb or gas emphysema and 10 (11.0 %) experienced pain during the procedure which was abated quickly when treated with intravenous analgesics. None of them required general anaesthesia. Three patients had late complications of rectal stenosis, at 5, 7 and 9 months after several sessions of treatment. They were treated conservatively with stool softener and symptoms had resolved over time.
The univariate analysis of various factors revealed statistically significant associations between patients' endoscopic severity (p = 0.044) and bleeding severity (p = 0.002) with number of APC sessions required to arrest the bleeding. There were no statistically significant associations between age, gender, ethnicity, primary disease and length of proctitis with the number of treatment required by patients (Table 1) .
When analysed for independent factors with multivariate regression analysis, only bleeding severity were found to have statistically significant association with the number of APC sessions required to stop the bleeding (p = 0.002). From the crosstabs, as the severity of bleeding increased, the number of APC sessions required also increased.
Discussion
This is a review of our single institution experience with the use of APC from January 2003 to December 2013 in the management for HRP. Our series demonstrates that APC is feasible, easy to perform and efficacious, and has a good safety profile if performed correctly. In addition, most patients were comfortable during the procedure, requiring only low level of sedation. In terms of efficacy of haemostasis, majority of patients (79.1 %) achieve successful regression of bleeding after 1-2 intervention. Our results are consistent with findings from a systemic review involving 416 patients showing treatment success in terms of improvement or complete resolution of symptoms in 406 (98 %) of patients [1] . In addition, most studies reported that patients did not require sedation or analgesia [4, 7] and successful treatment achieved after 1-2 sessions of APC [8, 9] . In our series, we recorded a mean number of 1.86 sessions of APC for successful haemostasis. Whether this is a result of improved experience and expertise with the widespread use of APC over the years is difficult to conclude. Nevertheless, it is reasonable to conclude that APC is effective in controlling haematochezia caused by radiation proctitis, in most cases after two treatment sessions.
Major complications following APC such as gas explosion, rectovaginal fistula, perforation with pneumoperitoneum, chronic rectal ulceration and stenosis have been reported in the literature. These complications, although rare, did not manifest in our series, except for rectal stenosis which was managed conservatively. The pathophysiology of the gas explosion remains unclear with no plausible answers. Poor bowel preparation using enemas have been attributed to as the cause of colonic explosion in one study and hence complete bowel preparation was advocated [10] . In our study, full bowel preparation was performed for colonoscopy, while rectal enemas alone were given to those required repeated endoscopic sessions with no untoward incidents. In addition, we implement a cautious practice of not performing endoscopic intervention in the presence of faeces over the telangiectatic surface. The thermal effects of APC on human tissue are related to the rate and duration of heating and the attained temperature. In practical term, the power setting and activation time are important consideration. Studies that reported APC was safe used an output setting of 40-60 W [2, 4, 7, 8] . A similar safety profile was observed in our study that used a power setting of 50 to 60 W. Brief pulses of 1 to 2 s should be used to minimize the depth of thermal penetration, thus the risks of perforation, excessive ulceration and stricture.
There is some controversy regarding the factors that correlate with the number of interventions required to achieve haemostasis. Some studies have reported that the endoscopic grade of HRP correlates with the severity of bleeding and the number of interventions required for haemostasis [11, 12] . However, these findings were disputed by a more recent prospective study by Swan MP et al. involving 50 patients [8] . They concluded that endoscopic grade was not the predictor of treatment success but rather the bleeding score. In our study, bleeding severity was utilized instead of bleeding score. Univariate analysis identified an association between patients' endoscopic grading and bleeding severity with the number of APC sessions required to achieve haemostasis. However, multivariate regression analysis identified only the bleeding severity as the only independent predictive factor. Nevertheless, there is a lack of uniformity in the description of endoscopic grading of HRP. Some studies employed the endoscopic grading system based on the area and the length of affected mucosa and the presence of active bleeding to categorize the severity into three grades: mild, moderate and severe [8, 11] , while another used a modified two-grade scale to divide the endoscopic severity into mild or severe disease [12] . Further research with a consensual endoscopic grading scale is needed to assess the correlation between endoscopic grading of severity and the success of treatment. Previous studies have identified an association between the extent of the proctitis and the number of treatment sessions required [2] . However, there was no statistical significant correlation between the length of proctitis and the number of treatment required by patients in our group. Similarly, there were no statistically significant associations between age, gender, ethnicity and primary disease with the number of treatment sessions.
Conclusions
Our results demonstrate that endoscopic haemostasis using APC is associated with good outcomes for treating HRP. In addition, this series demonstrates that the severity of initial bleeding has bearing on the number of endoscopic interventions required to achieve clinical resolution.
